Tempest Therapeutics Inc.

07/07/2026 | Press release | Distributed by Public on 07/08/2026 04:03

Notice of Effectiveness (Form EFFECT)

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date: July 7, 2026 4:00 P.M.
Form: S-3
CIK: 0001544227
Company Name: Tempest Therapeutics, Inc.
File Number: 333-297061
Tempest Therapeutics Inc. published this content on July 07, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on July 08, 2026 at 10:03 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]